Related Experiment Video
Updated: Sep 18, 2025

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Regiospecific hydroxylase and O-methyltransferase for the biosynthesis of anticancer alkaloids in Tabernaemontana
Scott Galeung Alexander Mann1, Matthew Bailey Richardson1, Rochelle Nicola Young1
1Department of Chemistry, University of New Brunswick, Fredericton, NB, E3B 5A3, Canada.
Abstract:
Monoterpenoid indole alkaloids (MIAs) are a structurally diverse class natural products with significant medicinal properties. Bis-MIAs, such as chemotherapeutic vinblastine and anti-autophagic conodurine, are synthesized through enzymatic coupling of monomeric MIAs, often requiring specific modifications to activate reactive centers. In this study, we report the identification and characterization of a regiospecific enzyme pair, coronaridine 11-hydroxylase (TeC11H) and 11-hydroxycoronaridine O-methyltransferase (TeHCOMT), from Tabernaemontana elegans (toad tree). The C11-methoxylation of coronaridine activates C10 and C12 on the indole for subsequent coupling with a vobasinyl monomer, representing a critical transformation in the biosynthesis of a series of 11-methoxycoronaridine derived bis-iboga-vobasinyl MIAs in T. elegans root with potent anticancer and anti-autophagy activities. Biochemical analysis and homology modeling of TeC11H and TeHCOMT, along with their Tabernanthe iboga (iboga) homologs for coronaridine C10-methoxylation, reveal key residues at their highly similar active sites responsible for distinct regioselectivity, demonstrating how coronaridine is oriented to favour C11 or C10 methoxylation. Our discovery sheds light on the coordinated specification of active sites in metabolically linked enzymes during evolutionary adaptation in different lineages. TeC11H and TeHCOMT represent a valuable tool for metabolic engineering, offering new opportunities to biosynthesize anticancer alkaloids and explore the therapeutic potential of novel bis-MIAs.
Related Concept Videos
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Drugs that Stabilize Microtubules
Biosynthesis of Nucleic Acids
Epigenetic Regulation
X-chromosome...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Drugs that Destabilize Microtubules

